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Tubular injury and interstitial ﬁbrosis are the hallmarks of
chronic kidney disease. While recent studies have veriﬁed
that proximal tubular injury triggers interstitial ﬁbrosis, the
impact of ﬁbrosis on tubular injury and regeneration
remains poorly understood. We generated a novel mouse
model expressing diphtheria toxin receptor on renal
ﬁbroblasts to allow for the selective disruption of renal
ﬁbroblast function. Administration of diphtheria toxin
induced upregulation of the tubular injury marker Ngal and
caused tubular proliferation in healthy kidneys, whereas
administration of diphtheria toxin attenuated tubular
regeneration in ﬁbrotic kidneys. Microarray analysis
revealed down-regulation of the retinol biosynthesis
pathway in diphtheria toxin-treated kidneys. Healthy
proximal tubules expressed retinaldehyde dehydrogenase
2 (RALDH2), a rate-limiting enzyme in retinoic acid
biosynthesis. After injury, proximal tubules lost RALDH2
expression, whereas renal ﬁbroblasts acquired strong
expression of RALDH2 during the transition to
myoﬁbroblasts in several models of kidney injury. The
retinoic acid receptor (RAR) RARg was expressed in
proximal tubules both with and without injury, and aB-
crystallin, the product of an RAR target gene, was strongly
expressed in proximal tubules after injury. Furthermore,
BMS493, an inverse agonist of RARs, signiﬁcantly
attenuated tubular proliferation in vitro. In human biopsy
tissue from patients with IgA nephropathy, detection of
RALDH2 in the interstitium correlated with older age and
lower kidney function. These results suggest a role of
retinoic acid signaling and cross-talk between ﬁbroblasts
and tubular epithelial cells during tubular injury and
regeneration, and may suggest a beneﬁcial effect of
ﬁbrosis in the early response to injury.
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R enal ﬁbrosis and tubular injury are the hallmarks ofchronic kidney disease and predict its prognosis. Renalﬁbrosis is mediated by the accumulation of myoﬁbro-
blasts,1 whose major origins have been identiﬁed as resident
ﬁbroblasts and pericytes.2–6 Because renal ﬁbroblasts are in
close contact with tubular epithelial cells, cross talk between
these 2 cell types has been proposed. We and another group
have generated proximal tubule–speciﬁc injury models using
proximal tubule–speciﬁc Cre strains7 and demonstrated that
proximal tubule injury triggers the activation of ﬁbroblasts
and pericytes, leading to ﬁbrosis.8,9
Although the role of proximal tubule injury in the pro-
gression of ﬁbrosis is well accepted, few studies have clariﬁed
the pathologic relevance of ﬁbrosis in the progression of
chronic kidney disease. Because the extent of interstitial
ﬁbrosis correlates well with renal prognosis, ﬁbrosis has been
considered as a self-sustained deteriorating process that in-
jures the adjacent nephrons. On the other hand, some in-
vestigators have argued the possibility that ﬁbrosis might have
a beneﬁcial impact. Fujigaki et al.10 observed the emergence
of myoﬁbroblasts around injured tubules in an acute kidney
injury model and postulated that ﬁbrosis might function as a
structural support for damaged nephrons during regenera-
tion. Kaissling et al.11 also proposed the concept that ﬁbrosis
itself is not deteriorating but might support tubular recovery.
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Whether ﬁbrosis is deteriorating in its nature or could be
beneﬁcial in some contexts is an essential question from the
standpoint of therapeutic application, yet the lack of com-
pounds capable of reversing ﬁbrosis hinders the analysis
necessary to answer it.
Here, we established a novel model of ﬁbroblast dysfunc-
tion and proposed possible beneﬁcial roles of ﬁbroblasts and
myoﬁbroblasts in healthy and diseased kidneys. We further
demonstrated that ﬁbroblasts acquire retinoic acid (RA)–
producing capacity during the transition to myoﬁbroblasts,
which possesses the capacity to promote the regeneration of
proximal tubules.
RESULTS
Fibroblast-speciﬁc expression of diphtheria toxin receptor in
the kidneys of P0-Cre:iDTR mice
Previously, we have shown that resident ﬁbroblasts in the
cortex and outer medulla of the kidney are lineage labeled with
P0-Cre transgenic mice12 and that they transdifferentiate into
myoﬁbroblasts during kidney injury.2 To halt protein synthesis
speciﬁcally in renal ﬁbroblasts, we crossed P0-Cre mice with i–
diphtheria toxin receptor (DTR) mice13,14 in which Cre
recombinase excises the STOP cassette and induces the
expression of DTR, also known as simian heparin-binding
epidermal growth factor–like growth factor (sHbegf)
(Figure 1a). DTR was effectively and speciﬁcally expressed in
the platelet–derived growth factor receptor (PDGFR)-bþ ﬁ-
broblasts in the interstitium of the cortex and outer medulla
but not in endothelial cells or hematopoietic cells (Figure 1b
and c). DTRþ cells in the cortex also expressed CD73, a cortical
ﬁbroblast marker (Figure 1b).
Loss of ﬁbroblast markers in the interstitium after diphtheria
toxin administration
Diphtheria toxin (DT) binds to its receptor on the cell sur-
face, is incorporated via endocytosis, and halts protein syn-
thesis in the target cell.13,15 We injected P0-Cre:iDTR mice
with 25 ng/g DT i.p. and humanely killed them 3 days after
the administration. Although histologic analysis did not show
any abnormalities except for sporadic vacuolation in proximal
tubules (Supplementary Figure S1A), immunostaining
revealed the ablation of PDGFR-b and CD73 expression but
not of CD45 or platelet endothelial cell adhesion molecule
(PECAM) expression, indicating the ﬁbroblast-speciﬁc
cessation of protein synthesis or the loss of ﬁbroblasts
(Figure 1d). We estimated the number of ﬁbroblasts in the
interstitium by staining hematopoietic cells and endothelial
cells before and after DT administration and found that some
of the ﬁbroblasts survive and reside in the interstitium after
DT administration, although the number of ﬁbroblasts
decreased to some extent (Supplementary Figure S1B).
Interestingly, the numbers of hematopoietic cells and endo-
thelial cells were not signiﬁcantly changed after DT treatment,
which excludes the possibility of severe inﬂammation or
capillary loss after DT treatment.
Signiﬁcant reduction of erythropoietin production after DT
administration
Previously we demonstrated that most erythropoietin (Epo)-
producing cells were lineage labeled with P0-Cre,2 but the
contribution of other populations to Epo production remains
unclear. The expression of Epo mRNA was completely abol-
ished in the kidneys of P0-Cre:iDTR mice after the adminis-
tration of DT (Figure 1e) and was not increased even in the
presence of severe hemolytic anemia induced by the admin-
istration of phenylhydrazine (Figure 1e), supporting our
previous conclusion that P0-Cre lineage-labeled ﬁbroblasts
predominantly contribute to Epo production.2
DT administration induces upregulation of neutrophil
gelatinase–associated lipocalin and tubular proliferation
Next, we focused on the phenotypic changes of tubular epithelial
cells in this system. Although DT administration did not cause
massive apoptosis in proximal tubules (Supplementary
Figure S1C), DT administration causes upregulation of neutro-
phil gelatinase–associated lipocalin (Ngal) mRNA and protein
(Figure 1f and g). Signiﬁcant proliferation of proximal tubules
shown by the immunostaining of Ki67 (Figure 1h) and MCM2
(Figure 1i) also was observed in the corticomedullary junction
after DT administration. We also conﬁrmed that the adminis-
tration of DT to P0-Cremice (without DTR) did not induce the
upregulation of Ngal, histologic injury, or renal dysfunction,
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Figure 1 | Diphtheria toxin (DT) administration to P0-Cre:iDTR mice abolishes erythropoietin (Epo) production, increases neutrophil
gelatinase–associated lipocalin (Ngal) expression, and induces tubular proliferation. (a) Schematic demonstration of P0-Cre mice and iDTR
mice. (b) Immunostaining of simian heparin-binding epidermal growth factor–like growth factor (sHBEGF; diphtheria toxin receptor: DTR) in the
kidney. sHBEGF was co-localized with platelet–derived growth factor receptor (PDGFR-b; a ﬁbroblast marker) and CD73 (a cortical ﬁbroblast
marker), but not with platelet endothelial cell adhesion molecule (PECAM; an endothelial marker) and CD45 (a leucocyte marker). (c) Graph
illustrating the proportion of PDGFRbþ interstitial cells expressing sHBEGF (%DTR/PDGFR-b) and the proportion of DTRþ interstitial cells
expressing PDGFR-b (%PDGFR-b/DTR). DTR was effectively and speciﬁcally expressed in the PDGFR-bþ ﬁbroblasts (n ¼ 4). (d) Immunostaining of
PDGFR-b, CD73, PECAM, and CD45 before and after DT administration. DT administration ablated the expression of PDGFR-b and CD73 but not
CD45 or PECAM. (e) Real-time reverse transcriptase–polymerase chain reaction (RT-PCR) analysis showed signiﬁcant reduction of Epo mRNA
after DT administration even in the presence of severe anemia caused by phenylhydrazine (PHZ) administration (n ¼ 4–5). F¼ 18.26, P< 0.05 for
interaction; F¼ 20.56, P< 0.05 for DT; F¼ 21.57, P< 0.05 for PHZ. F and P values are from 2-way analysis of variance after Bonferroni’s post hoc
test. *P < 0.05. (f) Real-time RT-PCR and Western blot analysis revealed the strong induction of Ngal mRNA and protein after DT administration,
indicating the presence of tubular injury (n ¼ 6–8). Statistical analysis by Student t-test. *P < 0.05. (g) Immunostaining revealed the induction of
Ngal in Tamm Horsfall protein (THP)- or Na-Cl cotransporter (NCC)–positive distal tubules after DT administration, indicating the presence of
tubular injury. (h,i) Immunostaining of Ki67 (h) and MCM2 (i) showed the proliferation of proximal tubules in the corticomedullary junction after
DT administration. GADPH, glyceraldehyde-3-phosphate dehydrogenase. Bars ¼ 10 mm. To optimize viewing of this image, please see the
online version of this article at www.kidney-international.org.
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Figure 2 | Diphtheria toxin (DT) administration increases tubular injury markers and attenuates tubular regeneration in ﬁbrotic kidney.
(a) Immunostaining revealed the co-localization of simian heparin-binding epidermal growth factor–like growth factor (sHBEGF) with platelet–
derived growth factor receptor (PDGFR-b), a-SMA (a marker for myoﬁbroblast), and Collagen 1 in unilateral ureteral obstruction (UUO) kidneys
of P0-Cre:iDTR mice and the ablation of these expressions after DT administration. (b) Graphs illustrate that most aSMAþ interstitial cells co-
expressed sHBEGF (%sHBEGF/aSMA) and that most sHBEGFþ interstitial cells co-expressed a-SMA (%a-SMA/hHBEGF), indicating the effective
and speciﬁc expression of diphtheria toxin receptor (DTR) in myoﬁbroblasts (n ¼ 4). (c) Real-time reverse transcriptase–polymerase chain
reaction analysis revealed signiﬁcant upregulation of Kim1, neutrophil gelatinase–associated lipocalin (Ngal), and Osteopontin (n ¼ 5). Statistical
analysis by Student t-test. *P < 0.05. (d) Immunostaining of Ki67 and AQP1 (a marker of proximal tubules). Numbers of Ki67þ proximal tubules
signiﬁcantly decreased after DT administration. (e) Graph illustrating the proportion of Ki67þ cells co-expressing AQP1 (continued)
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which excludes the possibility of the direct toxicity of DT
(Supplementary Figure S2A).
DT administration increases tubular injury markers and
attenuates tubular proliferation in ﬁbrotic kidney
We next investigated the role of myoﬁbroblasts in the uni-
lateral ureteral obstruction (UUO) model using the same
system.
DTRþ cells in UUO kidney of P0-Cre:iDTR mice were
positive for PDGFR-b, a-SMA, and collagen 1 (Figure 2a,
upper panel). DTR was effectively and speciﬁcally expressed
in myoﬁbroblasts (Figure 2b). The administration of DT to
P0-Cre:iDTR mice with UUO signiﬁcantly decreased the
expression of DTR, PDGFR-b, a-SMA, and collagen 1
(Figure 2a, lower panel). These results support our previous
ﬁndings that most myoﬁbroblasts are linage labeled with P0-
Cre and are transdifferentiated from resident ﬁbroblasts.2
Although histologic change was not obvious in periodic
acid–Schiff staining (Supplementary Figure S1A), the
expression levels of Kim1, Ngal, and osteopontin mRNA were
signiﬁcantly increased in UUO kidneys after DT administra-
tion (Figure 2c).
We also examined the effect of DT administration on
tubular proliferation. Whereas Ki67 staining was abundantly
detected in tubular epithelial cells in UUO kidneys, the
number of Ki67-positive cells was signiﬁcantly decreased after
the administration of DT (Figure 2d), and this decrease was
most prominent in the proximal tubules (Figure 2e,
Supplementary Figure S2B). Because tubular proliferation is
essential for tubular regeneration, reduction of tubular pro-
liferation possibly attenuates tubular regeneration.
Dysregulation of RA signaling pathway in DT-treated kidney
To explore how DT administration to the mice expressing
DTR in ﬁbroblasts affects tubular maintenance, we performed
microarray analysis with use of the kidneys of P0-Cre:iDTR
mice with or without DT administration. We selected the
transcripts that were upregulated or downregulated more
than 2-fold (2329; Supplementary Table S1), as well as those
that were expressed more than 5 times higher in the kidneys
than in other tissues (1311); pairwise comparisons of these
groups revealed 275 transcripts common to each group
(Figure 3a).
These transcripts were uploaded to Ingenuity Pathways
Analysis, which identiﬁed the dysregulation of genes involved
in retinol biosynthesis as the most statistically signiﬁcant.
Additionally, the software identiﬁed the dysregulation of
genes involved in stearate biosynthesis, leucine degradation,
mineralocorticoid biosynthesis, and serotonin receptor
signaling (Table 1).
Whereas RA signaling is essential in prenatal kidney devel-
opment, the role of RA signaling after birth remains unclear.16
Dietary carotenoid and retinyl ester are absorbed in the intes-
tine and converted into retinol, which binds to retinol binding
protein 4 (RBP4) and transthyretin (TTR). The retinol-RBP-
TTR complex is taken up by the target cells through an RBP
receptor called “stimulated by RA 6” (STRA6; Figure 3b).17,18
After entering the target cells, retinol binds to RBP1, a cellular
retinol binding protein, and is either esteriﬁed to be stored in
the cells19 or oxidized into retinal. Retinal is ﬁnally converted to
RA by retinaldehyde dehydrogenase (Figure 3b)20,21 and then
can bind to nuclear receptors including RARs and RXRs. The
role of RA signaling and the expression of its key molecules have
been extensively analyzed in the liver but not in the kidney.
Immunostaining demonstrated that STRA6 was expressed
exclusively in the basolateral sides of the proximal tubules in
healthy kidneys, indicating the possible uptake of retinol from
peritubular capillaries. STRA6 expression in the proximal tu-
bules was downregulated after DT administration (Figure 3c) as
conﬁrmed by Western blotting in UUO kidneys (Figure 3d).
Relocation of RA-producing capacity from proximal tubules
to myoﬁbroblasts
Among the retinaldehyde dehydrogenases (RALDHs),
RALDH-1, -2, and -3 convert retinal to RA, and the relative
contributions of these enzymes differ between cells and tis-
sues.22 GeneChip analysis in the Gene Expression Omnibus
(GEO) database comparing healthy and UUO kidneys23
showed that RALDH2 expression was signiﬁcantly upregu-
lated in UUO kidneys (Supplementary Figure S3A), whereas
RALDH1 expression was comparable between healthy and
UUO kidneys. RALDH3 was almost absent in both healthy
and UUO kidneys.
We also found that the expression of RALDH2 mRNA and
protein was signiﬁcantly upregulated in UUO kidneys of P0-
Cre:iDTR mice (Figure 3d and e), whereas the expression of
RALDH1 mRNA was comparable between healthy and UUO
kidneys (Supplementary Figure S3B). In immunostaining,
RALDH1 expression was observed in tubular epithelial cells in
both healthy and UUO kidneys (Supplementary Figure S3C).
On the contrary, the faint expression of RALDH2 in the
proximal tubules of healthy kidneys vanished after UUO
(Figure 3c). Alternatively, strong RALDH2 expression was
seen in the interstitium of UUO kidneys and was co-localized
with PDGFR-b and a-SMA (Figure 3c and f) but was abol-
ished by the administration of DT (Figure 3c) as conﬁrmed by
real-time reverse transcriptase–polymerase chain reaction
analysis and Western blotting (Figure 3d and e). We also
sorted ﬁbroblasts and myoﬁbroblasts from healthy and
ﬁbrotic kidneys utilizing P0-Cre:R26tdTomato mice and
=
Figure 2 | (continued) (a marker of proximal tubules), Tamm Horsfall protein, or Na-Cl cotransporter (markers of distal tubules) and AQP2 (a
marker of collecting ducts) in each segment before and after DT administration (n ¼ 4). F¼ 31.63, P< 0.05 for interaction; F¼ 98.80, P< 0.05 for
DT; F¼ 37.48, P< 0.05 for tubular segment. F and P values are from 2-way analysis of variance after Bonferroni’s post hoc test. NT, nontreated.
*P < 0.05. Bars ¼ 10 mm (a), 50 mm (d). To optimize viewing of this image, please see the online version of this article at www.kidney-
international.org.
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veriﬁed the induction of RALDH2 mRNA in myoﬁbroblasts
(Figure 3g).
Taken together, the evidence suggests that myoﬁbroblasts
acquire strong expression of RALDH2 during the transition from
ﬁbroblasts, whereas proximal tubules lose their RALDH2
expression upon injury. A previous study that analyzed the
transcriptional proﬁles of medullary myoﬁbroblasts using
translational ribosome afﬁnity puriﬁcation identiﬁed the
RALDH2 gene as one of the genes upregulated in
myoﬁbroblasts.24
Reversible acquisition of RA-producing ability by myoﬁbro-
blasts in various types of kidney disease models. Next we
analyzed the expression proﬁle of RALDH2 in other kidney
disease models with tubular injury and interstitial ﬁbrosis,
namely, an adenine nephropathy (AN) model and a severe
ischemic reperfusion injury (IRI) model induced by 45-
minute ischemia (Figure 4a).
Similar to the results seen in the UUO model, the faint
RALDH2 expression in the proximal tubules disappeared in
diseased kidneys, whereas a strong expression emerged in
myoﬁbroblasts as observed in the UUO model (Figure 4a).
The upregulation of RALDH2 mRNA and protein also was
conﬁrmed by real-time reverse transcriptase–polymerase
chain reaction analysis and Western blotting (Figure 4b).
We also examined whether the relocation of RALDH2
expression from the proximal tubules to the myoﬁbroblasts is
reversible utilizing 3 types of reversible kidney disease models,
reversible UUO (rUUO), reversible moderate IRI, and revers-
ible AN (Supplementary Figure S4). In these models, the strong
expression of RALDH2 in myoﬁbroblasts disappeared after
kidney regeneration (Figure 4c) as conﬁrmed by real-time
reverse transcriptase–polymerase chain reaction analysis
(Figure 4d).
Expression of RAR-g in proximal tubules but not in ﬁbro-
blasts. In adult kidneys, RA agonists reduce tubular injury
and attenuate ﬁbrosis in various kidney injury models.25–29 To
explore the RA action site, we analyzed the localization of the
RA receptor (RAR) family and found that RAR-g was expressed
in proximal tubules (Figure 5). The expression of RA receptors
in the interstitium, however, was sparse even in injured kidneys,
suggesting that RA might primarily act on proximal tubules and
induce their regeneration by its binding to RAR-g.
Possible function of RA signaling in proximal tubules
We further analyzed the possible function of RA signaling
in tubular epithelial cells and found that the administration
of BMS493, an inverse agonist of pan-retinoic acid re-
ceptors, to NRK52E cells, a tubule cell line, attenuated
tubular cell proliferation (Figure 6a). In addition, the
expression of Ki67 mRNA, total cell number, and BrdU
incorporation were lower in the presence of BMS493
(Figure 6b and c). These results indicate the importance of
RA in tubular cell proliferation. We also explored RA
downstream signaling in injured kidneys and found that in
healthy kidneys, aB-crystallin, the product of an RAR
target gene,30 was expressed only sparsely in the S3 segment
of proximal tubules, parietal epithelial cells of glomeruli,
and medullary epithelial cells (Figure 6d) but was strongly
upregulated only in proximal tubules in injured kidneys
(Figure 6e and f).
=
Figure 3 | Dysregulation of retinoic acid (RA) signaling pathway in diphtheria toxin (DT)–treated kidney. (a) We identiﬁed 2329
differentially expressed transcripts (red) that showed at least a 2-fold change in gene expression in P0-Cre:iDTR kidneys compared with control subjects,
and 1311 transcripts (blue) that showed expression levels at least 5 times higher in the kidneys than in other tissues. Pathway analysis was performed
on the 275 transcripts that were in both groups. (b) Schematic drawing of RA metabolism. (c) Immunostaining of key molecules in RA metabolism
(stimulated by RA 6 [STRA6], retinaldehyde dehydrogenase [RALDH]2) in normal kidney (control) and unilateral ureteral obstruction (UUO) kidney with
or without DT administration. (d) Western blot analysis and the quantiﬁcation of the bands showed that STRA6 expression in UUO kidneys was
decreased after DT administration (n¼ 4). F¼ 1.96, P¼ 0.1867 for interaction; F¼ 9.11, P< 0.05 for UUO; F¼ 5.86, P< 0.05 for DT. Western blot analysis
and quantiﬁcation of the bands also showed that RALDH2 expression was signiﬁcantly increased in UUO kidneys but was decreased after DT
administration (n ¼ 4). F¼ 83.41, P< 0.05 for interaction; F¼ 42.33, P< 0.05 for UUO; F¼ 37.21, P< 0.05 for DT. F and P values are from 2-way analysis
of variance (ANOVA) after Bonferroni’s post hoc test. *P< 0.05. (e) Real-time reverse transcriptase–polymerase chain reaction (RT-PCR) analysis revealed
that the expression levels of RALDH2 were increased in UUO kidneys but were signiﬁcantly decreased after DT administration (n ¼ 5-8). F¼ 91.49,
P< 0.05 for interaction; F¼ 67.84, P< 0.05 for UUO; F¼ 507.64, P< 0.05 for DT. F and P values are from 2-way ANOVA after Bonferroni’s post hoc test.
*P < 0.05. (f) RALDH2-positive interstitial cells were also positive for a-SMA (a marker of myoﬁbroblasts). (g) Real-time RT-PCR analysis revealed sig-
niﬁcant induction of RALDH2 expression in CD31–CD45-Tomatoþ cells (CD31-CD45-P0) isolated from P0-Cre:R26tdTomato mice in UUO kidneys (n¼ 3).
Statistical analysis by Student t-test. *P < 0.05. Bars ¼ 20 mm. Ces, carboxylesterase; n.s., not signiﬁcant; DAPI, 40,6-diamidino-2-phenylindole; GADPH,
glyceraldehyde-3-phosphate dehydrogenase; PDGFR, platelet–derived growth factor receptor; RAR, retinoic acid receptor; RARE, retinoic acid response
element; RBP1, retinol binding protein 1; RBP4: retinol binding protein 4; RXR, retinoid X receptor; RXRE, retinoid X response element; TTR, transthyretin.
To optimize viewing of this image, please see the online version of this article at www.kidney-international.org.
Table 1 | Top 5 signaling pathways identiﬁed by Ingenuity Pathways Analysis
Ingenuity Canonical Pathways -log (P value) Ratio Molecules
Retinol biosynthesis 3.55 8.2E-02 Ces1e,AADAC,RDH10,Ces1d,Ces2b/Ces2c
Stearate biosynthesis I (animals) 3.14 8E-02 Ces1e,DHCR24,Acot1,ACSL1
Leucine degradation I 2.35 7.69E-02 BCAT1,IVD
Mineralocorticoid biosynthesis 2.26 9.52E-02 HSD3B2,Hsd3b4 (includes others)
Serotonin receptor signaling 2.2 6.52E-02 DDC,SLC18A1,PCBD1
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Acquisition of RALDH2 expression by myoﬁbroblasts in
human kidney disease
RALDH2 expression also was analyzed in kidney biopsy sam-
ples of patients with IgA nephropathy. Whereas RALDH2 was
strongly expressed in healthy tubular epithelial cells (Figure 7a,
left), it also was detected in the interstitium of some biopsy
samples (Figure 7a, right). Patients with positive RALDH2
staining in the interstitium were signiﬁcantly older and had
lower kidney function (Figure 7b). Other characteristics
including sex and risk factors such as hypertension, diabetes
mellitus, and dyslipidemia were not signiﬁcantly different be-
tween the 2 groups. 2
DISCUSSION
In this study, we successfully generated a novel mouse model
expressing DTR on renal ﬁbroblasts and demonstrated that the
administration of DT to healthy kidneys causes the upregulation
of Ngal and the proliferation of tubular cells, whereas the
administration of DT to ﬁbrotic kidneys inhibits tubular pro-
liferation.We further proposed that RA signalingmight be one of
the signaling pathways modiﬁed by DT administration, which
has the potential to improve tubular regeneration. More
importantly, we demonstrated the relocation of RALDH2
expression from proximal tubules to myoﬁbroblasts during
kidney injury and showed that this relocation is reversible after
regeneration. The acquisition of RALDH2 expression by myo-
ﬁbroblasts also was observed in IgA nephropathy; the patients
with RALDH2 staining in the interstitium were older and had
lower kidney function. These results provide clear evidence of the
beneﬁcial role of ﬁbrosis in the kidney, at least in the early phase,
and provide insight into the long-lasting debate regarding the
role of ﬁbrosis in the progression of kidney disease.
In our previous work, we demonstrated that proximal tubule
injury induces the transition from ﬁbroblasts to myoﬁbro-
blasts.8 Together with the ﬁndings reported in this article, the
evidence suggests that proximal tubules lose their RA-producing
ability during injury and alternatively endow ﬁbroblasts with
RA-producing ability by inducing their transition to myoﬁ-
broblasts, which might support the regeneration of tubular
epithelial cells.
Resident ﬁbroblasts are capable of producing various fac-
tors that act on other cell types and tissues in the body.
Cortical ﬁbroblasts, for example, possess Epo-producing
ability in healthy kidneys,31 although they lose this ability in
the transition to myoﬁbroblasts and acquire extracellular
matrix-producing ability instead.2 In aged kidneys, in
contrast, resident ﬁbroblasts acquire the ability to produce
homeostatic chemokines such as CXCL13 and CCL19, attract
lymphocytes, and initiate the formation of tertiary lymphoid
tissues, causing sustained inﬂammation and retarding kidney
regeneration.32 The RA-producing ability reported in this
article is a new role for the myoﬁbroblasts, which might
support the regeneration of injured tubules. Fibroblasts are
highly plastic and can acquire various roles in response to
their microenvironment, then inﬂuence the microenviron-
ment with their newly acquired phenotypes. Further analysis
of the plasticity and diversity of ﬁbroblasts will provide us
with important clues to understand the renal microenviron-
ment in various types of kidney diseases.
In our experimental model, some ﬁbroblasts survive after
DTadministration. Indeed, we did observe ﬁbroblast-like cells
in the interstitium by electron microscopy after the admin-
istration of DT (Supplementary Figure S5A). The length of
the interval between DT administration and cell death is ex-
pected to vary between cell types depending on each type’s
protein synthesis requirements. In our previous work,8
proximal tubules with DTR expression were severely injured
3 days after the administration of DT and thus appear to be
highly dependent on protein synthesis. The major limitation
of our experiment, in fact, is the lack of long-term experi-
ments in the UUO model. We were only able to observe P0-
Cre:iDTRmice within 3 days after DT administration, because
these mice subsequently became sick, possibly as a result of
dysfunction of P0-Cre lineage-labeled cells throughout the
body. An analysis of long-term renal outcomes after the
depletion of myoﬁbroblasts is required to determine whether
ﬁbrosis is beneﬁcial or detrimental in the progression of
kidney diseases.
Recently, 2 other investigative groups have analyzed the
consequences of pericyte depletion. In FoxD1-Cre:iDTR mice,
Lemos et al.33 observed acute kidney injury together with
endothelial cell swelling and peritubular capillary loss 96
hours after the administration of DT. This severe phenotype
of FoxD1-Cre:iDTR mice compared with our results might be
=
Figure 4 | Acquisition of retinoic acid (RA)–producing ability by myoﬁbroblasts in various types of kidney disease models. (a)
Immunostaining revealed strong retinaldehyde dehydrogenase 2 (RALDH2) expression in the interstitium in adenine nephropathy (AN) and
severe ischemic reperfusion injury (IRI) that co-localized with platelet–derived growth factor receptor (PDGFR-b), a marker of ﬁbroblasts and
myoﬁbroblasts. (b) Real-time reverse transcriptase–polymerase chain reaction (RT-PCR) analysis revealed the induction of RALDH2 expression in
these models (n ¼ 4–5). One-way analysis of variance (ANOVA) with repeated measurements and Bonferroni post hoc tests. *P < 0.05. Western
blot analysis also showed strong upregulation of RALDH2 expression both in AN and severe IRI models (n ¼ 4). (c) Immunostaining of RALDH2,
a-SMA, and Kim1 in reversible kidney disease models: reversible unilateral ureteral obstruction (rUUO), moderate IRI, and AN. Immunostaining
of the kidneys at day 3 of rUUO, day 4 of moderate IRI, and day 3 of AN showed tubular injury and RALDH2 expression in myoﬁbroblasts. The
repaired kidneys also were examined 14 days after releasing the UUO clamps (rUUO Rday 14 [14 days after releasing the ligation of the ureter]),
45 days after moderate IRI (moderate IRI day 45), and 3 weeks after reverting from a diet containing adenine to a normal diet (AN R3 week).
Immunostaining of the repaired kidneys showed the disappearance of RALDH2 and a-SMA expression in the interstitium and Kim1 expression
in the tubular epithelial cells. (d) Real-time RT-PCR analysis revealed that RALDH2 expression was markedly increased in diseased kidneys and
signiﬁcantly decreased to basal levels in repaired kidneys (n ¼ 4–6). One-way ANOVA with repeated measurements and Bonferroni post hoc
tests. GADPH, glyceraldehyde-3-phosphate dehydrogenase; NT, nontreated; PDGFR, platelet–derived growth factor receptor. *P < 0.05. Bars ¼
20 mm. To optimize viewing of this image, please see the online version of this article at www.kidney-international.org.
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attributable to the recombination in different cell types.
Whereas FoxD1-Cre causes recombination in all pericytes/ﬁ-
broblasts in the kidney, P0-Cre causes recombination in ﬁ-
broblasts in the cortex and outer medulla. Additionally,
FoxD1-Cre causes recombination in vascular smooth muscle
cells, mesangial cells, and podocytes.34 Different recombina-
tion in pericytes/ﬁbroblasts in the inner medulla and other
cell types might contribute to the endothelial cell damage in
FoxD1-Cre:iDTR mice, which, in turn, causes an abrupt in-
crease in serum Cr. In Gli1CreERt2:iDTR mice, Kramann
et al.35 showed endothelial cell damage and transient proximal
tubule injury 10 days after DT administration and capillary
loss 56 days after DT administration. In their article, the
authors attributed the transient tubular injury to hypoxia as a
consequence of capillary rarefaction. The timing of the
analysis in this article is later than ours (day 3), which might
contribute to the different behaviors in endothelial cells.
Importantly, we observed proximal tubule injury without a
signiﬁcant reduction in endothelial cells (Supplementary
Figure S1B) or capillary density (Supplementary
Figure S5B) or turbulence in the capillary ﬂow by live im-
aging (Supplemental Movie S1). The fact that we observed
Figure 5 | Retinoic acid receptors (RARs) expressed in tubular epithelial cells. Immunohistochemical analysis of C57/BL6j mouse kidneys
detected staining of RARs (RAR-a, -b and -g) in tubular epithelial cells in both nontreated (NT) and unilateral ureteral obstruction (UUO)
conditions. Whereas RARa and b were dominantly expressed in Tamm Horsfall protein (THP)/Na-Cl cotransporter (NCC)–positive distal tubules,
RARg was expressed in AQP1-positive proximal tubules in both NT and UUO kidneys. Arrowheads indicate the localization of RAR signals. Bars ¼
20 mm. To optimize viewing of this image, please see the online version of this article at www.kidney-international.org.
bas i c re sea r ch J Nakamura et al.: Beneﬁcial aspect of ﬁbrosis in kidney
10 Kidney International (2019) -, -–-
J Nakamura et al.: Beneﬁcial aspect of ﬁbrosis in kidney bas i c re sea r ch
Kidney International (2019) -, -–- 11
proximal tubule injury without obvious endothelial cell injury
indicates a possible new role of ﬁbroblasts in addition to the
previously established cross talk between ﬁbroblasts and
endothelial cells. Together with the previous ﬁndings, our
data suggest that ﬁbroblasts/pericytes, proximal tubules, and
peritubular capillaries are closely involved in mutual regula-
tion in healthy and injured kidneys.
RA signaling plays an essential role in kidney development36–39
and mediates the interaction between the ureteric bud and the
stromal mesenchyme during kidney development.40,41 RA
secreted by stromal cells expressing RALDH2 controls Ret
expression in the ureteric bud, which controls branching
morphogenesis. Indeed, in human kidney development, the
variants of RALDH2 determine the ﬁnal nephron number.42 The
observation that RA from stromal cells regulates the differentia-
tion of epithelial cells is similar to our ﬁndings that RA from
myoﬁbroblasts possibly regulates tubular regeneration.
Recently, Chiba et al.43 demonstrated that RA signaling in
the proximal tubules represses proinﬂammatory macrophages
and promotes renal regeneration after acute kidney injury.
Whereas myoﬁbroblasts expressed RALDH2 in the ﬁbrosis
model in our experiments, they showed that macrophages
expressed RALDH2 in the acute kidney injury model. The
source of RA might be variable depending on the type of
kidney injury. More importantly, our research group and that
of Chiba et al.43 have independently demonstrated the
importance of RA signaling during kidney injury and
regeneration. In the healthy liver, retinols are taken up by
hepatocytes and then transferred to ﬁbroblast-like hepatic
stellate cells, where they are stored as retinyl esters or
metabolized into RA.44 Previous reports have demonstrated
that renal ﬁbroblasts possess the capacity to store retinyl es-
ters.45 The upregulation of RALDH2 during the transition of
ﬁbroblasts to myoﬁbroblasts as shown here implies the pos-
sibility that RA synthesis occurs in myoﬁbroblasts.
In conclusion, ﬁbroblasts acquire RA-producing capacity
in the transition to myoﬁbroblasts and may stimulate tubular
regeneration. In our previous work, we proposed that ﬁbrosis
is secondary to tubular injury and that the treatment of
ﬁbrosis in its own right might be insufﬁcient to halt the
progression of kidney diseases.8 The ﬁndings in this study
further suggest the possible beneﬁcial effect of ﬁbrosis, at least
in the early phase, but the long-term effect of ﬁbrosis is still
unknown. Further analysis is required to identify any mo-
lecular marker that could enable us to distinguish beneﬁcial
ﬁbrosis from detrimental ﬁbrosis.
CONCISE METHODS
Statistical analysis
Differences between the 2 groups were compared using the Student
t-test for continuous variables and Fisher exact test for categorical
variables as appropriate. Continuous variables were presented as
mean  SD, and categorical variables were expressed as number and
percentage. Data in Figures 1e, 2e, 3d, 3e, 4b, and 4d were analyzed
using a repeated measure 1-way or 2-way analysis of variance to
obtain the Bonferroni adjusted P value and multiply the uncorrected
P value by the total number of comparisons. All tests were 2-tailed,
Figure 7 | Acquisition of retinaldehyde dehydrogenase 2
(RALDH2) expression by myoﬁbroblasts in human kidney
disease. (a) Representative images of the immunostaining of RALDH2
in biopsy samples from patients with IgA nephropathy. Whereas
RALDH2 was mainly detected in tubular epithelial cells and was
absent from the interstitium of the RALDH2– specimen (left), RALDH2-
positive interstitial cells with a ﬁbroblast-like morphology were
detected in the interstitium of the RALDH2þ specimen (right). (b)
Characteristics of the study populations of IgA nephropathy with or
without RALDH2 staining in the interstitium. Patients with positive
RALDH2 staining in the interstitium were older and had lower kidney
function. Other characteristics, including sex and risk factors such as
hypertension, diabetes mellitus, and dyslipidemia, were comparable
between the 2 groups. Percentages are shown in parentheses. BUN,
blood urea nitrogen; eGFR, estimated glomerular ﬁltration rate.
Bars ¼ 10 mm. To optimize viewing of this image, please see the
online version of this article at www.kidney-international.org.
=
Figure 6 | Possible retinoic acid (RA) signaling in proximal tubules. (a) Representative images of NRK52E in the presence or absence of
BMS493. The numbers of NRK52E cells were apparently lower in the presence of BMS493. (b,c) Real-time reverse transcriptase–polymerase
chain reaction (RT-PCR) analysis of Ki67 (b), the quantiﬁcation analysis of total cell numbers, and BrdU proliferation assay (c) after the treatment
with vehicle or BMS493. Statistical analysis by Student t-test. *P < 0.01. (d–f) Immunohistochemical analysis of nontreated (NT) and unilateral
ureteral obstruction (UUO) kidneys. (d,e) Immunoﬂuorescence of aB-crystallin, the product of a retinoic acid receptor (RAR) target gene, and
phalloidin (a marker of proximal tubule) in the cortex and cortico-medullary junction. (f) Immunoﬂuorescence of aB-crystallin and Tamm-
Horsfall protein (THP) (a marker of thick ascending limb), calbindin D28K (a marker of distal convoluted tubule7), E-cadherin (a marker of distal
convoluted tubule and collecting duct7), and platelet endothelial cell adhesion molecule (PECAM, a marker of endothelial cell). GADPH,
glyceraldehyde-3-phosphate dehydrogenase. Bars ¼ 200 mm (a), 50 mm (d–f). To optimize viewing of this image, please see the online version
of this article at www.kidney-international.org.
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and P values <0.05 or <0.01 were considered statistically signiﬁcant.
Student t-test and Fisher exact analyses were performed using JMP
13 software (SAS Institute, Cary, NC). One-way and 2-way analysis
of variance analyses were performed using STATA software version
15 (StataCorp LLC, College Station, TX).
Detailed materials and methods are found in Supplementary
Methods. Sequences of the primers used for real-time reverse tran-
scriptase–polymerase chain reaction are listed in Supplementary
Table S2.
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SUPPLEMENTARY MATERIAL
Figure S1. Analysis of histologic injury and cell numbers in the
interstitium of P0-Cre:iDTR mice after the administration of diphtheria
toxin (DT). (A) Histologic analysis was performed in a section stained
with periodic acid–Schiff. Histologic injury scores of nontreated
kidneys in P0-Cre:iDTR mice were not signiﬁcantly changed by the
administration of DT except for sporadic vacuolation in proximal
tubules. Histologic injury scores of unilateral ureteral obstruction
(UUO) kidneys in P0-Cre:iDTR mice were not signiﬁcantly changed by
the administration of DT. (B) The number of white blood cells,
endothelial cells, and ﬁbroblasts in the interstitium 3 days after DT
treatment. Control: control mice (n ¼ 4); DT: DT-treated mice (n ¼ 5).
(C) Immunostaining of caspase-3 and gH2AX revealed that massive
apoptosis was not observed in the proximal tubules of DT-treated
kidneys. Right panels indicate massive apoptosis in the kidney with
cisplatin-induced nephrotoxicity (CIN). Bar ¼ 20 mm (A), 50 mm (C).
Statistical analysis by Student t-test. n.s., not signiﬁcant. *P < 0.01.
Figure S2. Diphtheria toxin (DT) administration does not cause
toxicity in mice that do not express DT receptor (DTR), but it causes
the reduction of proximal tubule proliferation in P0-Cre:iDTR mice. (A)
Real-time reverse transcriptase–polymerase chain reaction analysis
revealed that Ngal mRNA was not signiﬁcantly increased in P0-
Cre:iDTR(-) mice kidneys after the administration of DT (n ¼ 4-6).
Histologic change in kidney sections stained with periodic acid–Schiff
or the elevation of serum creatinine (Cr) and blood urea nitrogen
(BUN) levels was not observed in P0-Cre:iDTR(-) mice after DT
administration. (B) Graph illustrating the proportion of Ki67þ cells in
proximal tubules of unilateral ureteral obstruction (UUO) kidneys in
P0-Cre:iDTR mice with or without DT administration (n ¼ 3). Proximal
tubule proliferation was signiﬁcantly attenuated after DT adminis-
tration. Bars ¼ 20 mm. GADPH, glyceraldehyde-3-phosphate dehy-
drogenase; n.s., not signiﬁcant. Statistical analysis by Student t-test:
(A) *P < 0.05; (B) *P < 0.01.
Figure S3. Expression proﬁles of retinaldehyde dehydrogenases
(RALDHs) in the kidney. (A) Graph illustrating the signal value of
RALDH1, RALDH2, and RALDH3 in sham and unilateral ureteral
obstruction (UUO) kidneys from GeneChip analysis in the National
Center for Biotechnology Information Gene Expression Omnibus
database (n ¼ 3). There were 3 probes for RALDH3. RALDH2
expression was signiﬁcantly upregulated in UUO kidneys, whereas
RALDH1 expression was comparable between healthy and UUO
kidneys. RALDH3 was almost completely absent from both healthy
and UUO kidneys. (B) Real-time reverse transcriptase–polymerase
chain reaction analysis conﬁrmed that RALDH1 expression was not
increased in UUO kidneys (n ¼ 5-8). RALDH1 expression was increased
after the administration of diphtheria toxin (DT) in both normal and
UUO kidneys. (C) Immunostaining revealed that RALDH1 staining was
detected in tubular epithelial cells but not in the interstitium. NT,
nontreated. Bars ¼ 50 mm. *P < 0.05. Statistical analysis by Student t-
test (A, B).
Figure S4. Histologic ﬁndings of reversible kidney disease models.
Kidneys from 3 types of reversible kidney disease models, namely,
reversible unilateral ureteral obstruction (rUUO), reversible moderate
ischemic reperfusion injury (IRI), and reversible adenine nephropathy
(AN), were analyzed in sections stained with periodic acid–Schiff. On
day 3 of rUUO, day 4 of moderate IRI, and day 3 of AN, the treated
kidneys showed tubular injury, whereas 14 days after releasing the
UUO clamps (rUUO R day 14), 45 days after moderate IRI (moderate
IRI day 45), and 3 weeks after reverting from an adenine-containing
diet to a normal diet (AN R 3 weeks), this injury was almost
completely repaired. Bars ¼ 20 mm.
Figure S5. Existence of ﬁbroblast-like cells in the interstitium and
maintained expression of platelet endothelial cell adhesion molecule
(PECAM) after the administration of diphtheria toxin (DT) in P0-Cre:iDTR
mice. (A) Electron microscopy revealed the existence of ﬁbroblast-like
interstitial cells (arrowhead) after the administration of DT in P0-Cre:iDTR
mice. (B) Immunostaining revealed that PECAM staining was not
signiﬁcantly decreased in DT-treated kidneys of P0-Cre:iDTRmice. Bars¼
(A) 2 mm, (B) 20 mm. The vessels in the DT-treated kidneys of P0-Cre:iDTR
mice are also visualized in Supplementary Movie S1.
Movie S1A. In vivo multi-photon imaging of P0-Cre:iDTR mouse kid-
neys (A, control mice without diphtheria toxin [DT] injection; B and C,
with DT injection). Tubules are visualized by the green auto-
ﬂuorescence signal. Texas-red bovine serum albumin was adminis-
tered i.v. to label the cortical peritubular capillaries (PTCs). Capillary
blood ﬂow was conﬁrmed by the shadows of circulating cells in PTCs.
Capillary ﬂow was maintained even after DT administration, and
neither red blood cell rouleaux formation nor leakage from capillary
to tubular lumen was detected (B). Very rarely, reduced PTC ﬂow was
observed around severely injured tubules (C). (A) Time series of PTC
ﬂow in the P0-Cre:iDTR mice without DT injection.
Movie S1B. Time series of PTC ﬂow in the P0-Cre:iDTR mice with DT
injection. Tubules in this image were almost intact.
Movie S1C. Time series of PTC ﬂow in the P0-Cre:iDTR mice with DT
injection. Injured tubules were observed in this image. Images were
taken over 50 s. Scale ¼ 50 mm.
Table S1. Result of Ingenuity Pathways Analysis.
Table S2. Sequences of primers used for real-time reverse
transcriptase–polymerase chain reaction.
Supplementary Methods.
Supplementary material is linked to the online version of the paper at
www.kidney-international.org.
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